AstraZeneca Beats Q2 Earnings Forecasts With Oncology and Rare Disease Growth

SentiSense · Published Jul 27, 2026, 2:05 AM ET · Updated Jul 27, 2026, 5:25 PM ET

AstraZeneca reported Q2 core EPS of $2.63, ahead of the roughly $2.48 expected, on revenue of about $15.38 billion that rose 5% but landed just short ...